Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209-49. https://doi.org/10.3322/caac.21660

Khorana AA. Venous thromboembolism and prognosis in cancer. Thromb Res. 2010;125(6):490-3. https://doi.org/10.1016/j.thromres.2009.12.023

Abdol Razak N, Jones G, Bhandari M, Berndt M, Metharom P. Cancer-Associated Thrombosis: An Overview of Mechanisms, Risk Factors, and Treatment. Cancers. 2018;10(10):380. https://doi.org/10.3390/cancers10100380

Colman RW, M. D. Clowes AW, Goldhaber SZ, Marder VJ, George JN, editors. Hemostasis And Thrombosis: Basic Principles And Clinical Practice. 5th edition. Philadelphia, Pa. London: Lippincott Williams & Wilkins; 2005. 1827 p.

Wojtukiewicz MZ, Hempel D, Sierko E, Tucker SC, Honn KV. Thrombin-unique coagulation system protein with multifaceted impacts on cancer and metastasis. Cancer Metastasis Rev. 2016;35(2):213-33. https://doi.org/10.1007/s10555-016-9626-0

Coughlin SR. Thrombin signalling and protease-activated receptors. Nature. 2000;407(6801):258-64. https://doi.org/10.1038/35025229

Wojtukiewicz MZ, Hempel D, Sierko E, Tucker SC, Honn KV. Protease-activated receptors (PARs)-biology and role in cancer invasion and metastasis. Cancer Metastasis Rev. 2015;34(4):775-96. https://doi.org/10.1007/s10555-015-9599-4

Tsopanoglou NE, Maragoudakis ME. Thrombin's central role in angiogenesis and pathophysiological processes. Eur Cytokine Netw. 2009;20(4):171-9. https://doi.org/10.1684/ecn.2009.0166

Danckwardt S, Hentze MW, Kulozik AE. Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond. J Mol Med. 2013;91(11):1257-71. https://doi.org/10.1007/s00109-013-1074-5

Kohli M, Williams K, Yao JL, Dennis RA, Huang J, Reeder J, Ricke WA. Thrombin expression in prostate: a novel finding. Cancer Invest. 2011;29(1):62-7. https://doi.org/10.3109/07357907.2010.535057

Shaker H, Bundred NJ, Landberg G, Pritchard SA, Albadry H, Nicholson SL, Harries LJ, Heah JYE, Castle J, Kirwan CC. Breast cancer stromal clotting activation (Tissue Factor and thrombin): A pre-invasive phenomena that is prognostic in invasion. Cancer Med. 2020;9(5):1768-78. https://doi.org/10.1002/cam4.2748

Wojtukiewicz MZ, Rucinska M, Zimnoch L, Jaromin J, Piotrowski Z, Rózanska-Kudelska M, Kisiel W, Kudryk BJ. Expression of Prothrombin Fragment 1+2 in Cancer Tissue as an Indicator of Local Activation of Blood Coagulation. Thromb Res. 2000;97(5):335-42. https://doi.org/10.1016/S0049-3848(99)00169-3

Tape CJ. The Heterocellular Emergence of Colorectal Cancer. Trends Cancer. 2017;3(2):79-88. https://doi.org/10.1016/j.trecan.2016.12.004

Dunjic S, Cumbo M, Gvozdenov M, Tomic B, Pruner I, Radojkovic D, Djordjevic V. Prothrombin expression in cancer-derived cell lines. Arch Biol Sci. 2019;71(1):49-54. https://doi.org/10.2298/ABS180829046D

Malki A, ElRuz RA, Gupta I, Allouch A, Vranic S, Al Moustafa A-E. Molecular Mechanisms of Colon Cancer Progression and Metastasis: Recent Insights and Advancements. Int J Mol Sci. 2020;22(1):130. https://doi.org/10.3390/ijms22010130

Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9(7):671-5. https://doi.org/10.1038/nmeth.2089

Fair D, Bahnak B. Human hepatoma cells secrete single chain factor X, prothrombin, and antithrombin III. Blood. 1984;64(1):194-204. https://doi.org/10.1182/blood.V64.1.194.194

Hu L, Lee M, Campbell W, Perez-Soler R, Karpatkin S. Role of endogenous thrombin in tumor implantation, seeding, and spontaneous metastasis. Blood. 2004;104(9):2746-51. https://doi.org/10.1182/blood-2004-03-1047

Sierko E, Wojtukiewicz MZ, Zimnoch L, Thorpe PE, Brekken RA, Kisiel W. Co-localization of prothrombin fragment F1+2 and VEGF-R2-bound VEGF in human colon cancer. Anticancer Res. 2011;31(3):843-7.

Franchini M, Lippi G. Prothrombin complex concentrates: an update. Blood Transfus Trasfus Sangue. 2010;8(3):149-54.

Ahmed D, Eide PW, Eilertsen IA, Danielsen SA, Eknæs M, Hektoen M, Lind GE, Lothe RA. Epigenetic and genetic features of 24 colon cancer cell lines. Oncogenesis. 2013;2(9):e71-e71. https://doi.org/10.1038/oncsis.2013.35

Leibovitz A, Stinson JC, McCombs WB, McCoy CE, Mazur KC, Mabry ND. Classification of human colorectal adenocarcinoma cell lines. Cancer Res. 1976;36(12):4562-9.

Fogh J, editor. Human Tumor Cells in Vitro. Boston, MA: Springer US; 1975. https://doi.org/10.1007/978-1-4757-1647-4

Brattain MG, Fine WD, Khaled FM, Thompson J, Brattain DE. Heterogeneity of malignant cells from a human colonic carcinoma. Cancer Res. 1981;41(5):1751-6.

Caro I, Boulenc X, Rousset M, Meunier V, Bourrié M, Julian B, Joyeux H, Roques C, Berger Y, Zweibaum A, Fabre G. Characterisation of a newly isolated Caco-2 clone (TC-7), as a model of transport processes and biotransformation of drugs. Int J Pharm. 1995;116(2):147-58. https://doi.org/10.1016/0378-5173(94)00280-I

Murphy N, Ward HA, Jenab M, Rothwell JA, Boutron-Ruault M-C, Carbonnel F, Kvaskoff M, Kaaks R, Kühn T, Boeing H, Aleksandrova K, Weiderpass E, Skeie G, Borch KB, Tjønneland A, Kyrø C, Overvad K, Dahm CC, Jakszyn P, Sánchez M-J, Gil L, Huerta JM, Barricarte A, Quirós JR, Khaw K-T, Wareham N, Bradbury KE, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Grioni S, Tumino R, Fasanelli F, Panico S, Bueno-de-Mesquita B, Peeters PH, Gylling B, Myte R, Jirström K, Berntsson J, Xue X, Riboli E, Cross AJ, Gunter MJ. Heterogeneity of Colorectal Cancer Risk Factors by Anatomical Subsite in 10 European Countries: A Multinational Cohort Study. Clin Gastroenterol Hepatol. 2019;17(7):1323-1331.e6. https://doi.org/10.1016/j.cgh.2018.07.030

Sobral D, Martins M, Kaplan S, Golkaram M, Salmans M, Khan N, Vijayaraghavan R, Casimiro S, Fernandes A, Borralho P, Ferreira C, Pinto R, Abreu C, Costa AL, Zhang S, Pawlowski T, Godsey J, Mansinho A, Macedo D, Lobo-Martins S, Filipe P, Esteves R, Coutinho J, Costa PM, Ramires A, Aldeia F, Quintela A, So A, Liu L, Grosso AR, Costa L. Genetic and microenvironmental intra-tumor heterogeneity impacts colorectal cancer evolution and metastatic development. Commun Biol. 2022;5(1):937. https://doi.org/10.1038/s42003-022-03884-x

Buikhuisen JY, Torang A, Medema JP. Exploring and modelling colon cancer inter-tumour heterogeneity: opportunities and challenges. Oncogenesis. 2020;9(7):66. https://doi.org/10.1038/s41389-020-00250-6

Patkulkar PA, Subbalakshmi AR, Jolly MK, Sinharay S. Mapping Spatiotemporal Heterogeneity in Tumor Profiles by Integrating High-Throughput Imaging and Omics Analysis. ACS Omega. 2023;8(7):6126-38. https://doi.org/10.1021/acsomega.2c06659

Beitia M, Romano P, Larrinaga G, Solano-Iturri JD, Salis A, Damonte G, Bruzzone M, Ceppi M, Profumo A. The Activation of Prothrombin Seems to Play an Earlier Role than the Complement System in the Progression of Colorectal Cancer: A Mass Spectrometry Evaluation. Diagnostics. 2020;10(12):1077. https://doi.org/10.3390/diagnostics10121077

Wiebe JP, Dinsdale CJ. Inhibition of cell proliferation by glycerol. Life Sci. 1991;48(16):1511-7. https://doi.org/10.1016/0024-3205(91)90275-G

Sakurai S, Okada Y, Mataga I. Inhibitory Effects of Glycerol on Growth and Invasion of Human Oral Cancer Cell Lines. J Hard Tissue Biol. 2011;20(1):37-46. https://doi.org/10.2485/jhtb.20.37

Hansen CB, van Deurs B, Petersen LC, Rao LV. Discordant expression of tissue factor and its activity in polarized epithelial cells. Asymmetry in anionic phospholipid availability as a possible explanation. Blood. 1999;94(5):1657-64. https://doi.org/10.1182/blood.V94.5.1657

Zhou H, Hu H, Shi W, Ling S, Wang T and Wang H: The expression and the functional roles of tissue factor and protease-activated receptor-2 on SW620 cells. Oncol Rep 2008;20:1069-76. https://doi.org/10.3892/or_00000111

Hisada Y, Mackman N. Tissue Factor and Cancer: Regulation, Tumor Growth, and Metastasis. Semin Thromb Hemost. 2019;45(04):385-95. https://doi.org/10.1055/s-0039-1687894

Mackman N. Role of Tissue Factor in Hemostasis, Thrombosis, and Vascular Development. Arterioscler Thromb Vasc Biol. 2004;24(6):1015-22. https://doi.org/10.1161/01.ATV.0000130465.23430.74

Pozzi N, Chen Z, Zapata F, Niu W, Barranco-Medina S, Pelc LA, Di Cera E. Autoactivation of Thrombin Precursors. J Biol Chem. 2013;288(16):11601-10. https://doi.org/10.1074/jbc.M113.451542

Zain J, Huang YQ, Feng X, Nierodzik ML, Li JJ, Karpatkin S. Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood. 2000;95(10):3133-8. https://doi.org/10.1182/blood.V95.10.3133

Degani G, Altomare A, Digiovanni S, Arosio B, Fritz G, Raucci A, Aldini G, Popolo L. Prothrombin is a binding partner of the human receptor of advanced glycation end products. J Biol Chem. 2020;295(35):12498-511. https://doi.org/10.1074/jbc.RA120.013692

Younessi P, Yoonessi A. Advanced glycation end-products and their receptor-mediated roles: inflammation and oxidative stress. Iran J Med Sci. 2011;36(3):154-66.

Fuentes MK, Nigavekar SS, Arumugam T, Logsdon CD, Schmidt AM, Park JC, Huang EH. RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways. Dis Colon Rectum. 2007;50(8):1230-40. https://doi.org/10.1007/s10350-006-0850-5

Schulze EB, Hedley BD, Goodale D, Postenka CO, Al-Katib W, Tuck AB, Chambers AF, Allan AL. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms. Breast Cancer Res Treat. 2008;112(2):243-54. https://doi.org/10.1007/s10549-007-9865-4

Vianello F, Sambado L, Goss A, Fabris F, Prandoni P. Dabigatran antagonizes growth, cell‐cycle progression, migration, and endothelial tube formation induced by thrombin in breast and glioblastoma cell lines. Cancer Med. 2016;5(10):2886-98. https://doi.org/10.1002/cam4.857

DeFeo K, Hayes C, Chernick M, Van Ryn J, Gilmour SK. Use of dabigatran etexilate to reduce breast cancer progression. Cancer Biol Ther. 2010;10(10):1001-8. https://doi.org/10.4161/cbt.10.10.13236